Galaxy Surfactants schedules analyst meetings on Sep 8 and 10
- Galaxy Surfactants schedules analyst meetings for September 8 and 10, 2026
- September 8 session is a non-deal roadshow hosted by Nuvama IE in Mumbai
- September 10 session involves 1x1 and group meetings in Mumbai
- All interactions are in-person and based on publicly available information
- No unpublished price-sensitive information will be discussed

*this image is generated using AI for illustrative purposes only.
Galaxy Surfactants has scheduled meetings with analysts and institutional investors on September 8 and September 10, 2026. The engagements will take place in Mumbai and include a non-deal roadshow hosted by Nuvama IE.
Meeting details
The company notified the National Stock Exchange of India Ltd and BSE Limited regarding the schedule under Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Discussions during these interactions will be based solely on publicly available information.
The firm confirmed that no unpublished price-sensitive information (UPSI) is intended to be discussed. Management noted that changes to the schedule may occur due to exigencies on the part of the host or the company.
| Date & Time | Nature of Meeting | Place | Mode |
|---|---|---|---|
| September 8, 2026 (9:00 am to 5:00 pm) | Non-Deal Roadshow Hosted by Nuvama IE | Mumbai | In-person |
| September 10, 2026 (9:00 am to 5:00 pm) | 1x1 / Group Meeting | Mumbai | In-person |
The intimation was signed by Niranjan Ketkar, Company Secretary, on September 3, 2026.
Historical Stock Returns for Galaxy Surfactants
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.67% | +1.03% | +7.06% | +16.81% | -10.01% | 0.0% |
How might Galaxy Surfactants' recent operational performance or margin trends influence the key themes discussed during this Nuvama-hosted roadshow?
What specific growth initiatives in international markets is Galaxy Surfactants likely to highlight to institutional investors given its current global expansion strategy?
Could the timing of these September 2026 meetings signal an upcoming capital allocation decision, such as a dividend revision, buyback, or new capacity investment?


































